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Abstract
Nucleosomes, which are typical cell death products, are
elevated in the serum of cancer patients and are known
to rapidly increase during radiotherapy. As both normal
and malignant cells are damaged by irradiation, we
investigated to which extent both cell types contribute to
the release of nucleosomes. We cultured monolayers of
normal bronchoepithelial lung cells (BEAS-2B, n = 18)
and epithelial lung cancer cells (EPLC, n = 18), exposed
them to various radiation doses (0, 10 and 30 Gy) and
observed them for 5 days. Culture medium was changed
every 24 h. Subsequently, nucleosomes were deter-
mined in the supernatant by the Cell Death Detection-
ELISAplus (Roche Diagnostics). Additionally, the cell num-
ber was estimated after harvesting the cells in a second
preparation. After 5 days, the cell number of BEAS-2B
cultures in the irradiated groups (10 Gy: median 0.03 !
106 cells/culture, range 0.02–0.08 ! 106 cells/culture;
30 Gy: median 0.08 ! 106 cells/culture, range 0.02–0.14
! 106 cells/culture) decreased significantly (10 Gy: p =
0.005; 30 Gy p = 0.005; Wilcoxon test) compared to the
non-irradiated control group (median 4.81 ! 106 cells/
culture, range 1.50–9.54 ! 106 cells/culture). Consistent-
ly, nucleosomes remained low in the supernatant of non-
irradiated BEAS-2B. However, at 10 Gy, BEAS-2B
showed a considerably increasing release of nucleo-
somes, with a maximum at 72 h (before irradiation: 0.24
! 103 arbitrary units, AU, range 0.13–4.09 ! 103 AU, and
after 72 h: 1.94 ! 103 AU, range 0.11–5.70 ! 103 AU). At
30 Gy, the release was even stronger, reaching the maxi-
mum earlier (at 48 h, 11.09 ! 103 AU, range 6.89–18.28
! 103 AU). In non-irradiated EPLC, nucleosomes con-
stantly increased slightly. At 10 Gy, we observed a con-
siderably higher release of nucleosomes in EPLC, with a
maximum at 72 h (before irradiation: 2.79 ! 103 AU,
range 2.42–3.80 ! 103 AU, and after 72 h: 7.16 ! 103 AU,
range 4.30–16.20 ! 103 AU), which was more than 3.5
times higher than in BEAS-2B. At 30 Gy, the maximum
(6.22 ! 103 AU, range 5.13–9.71 ! 103 AU) was observed
already after 24 h. These results indicate that normal
bronchoepithelial and malignant lung cancer cells con-
tribute to the release of nucleosomes during irradiation
in a dose- and time-dependent manner with cancer cells
having a stronger impact at low doses.
Copyright © 2004 S. Karger AG, Basel
322 Tumor Biol 2004;25:321–326 Holdenrieder/Stief/Bergner/Gamarra/
Mitlewski/Nagel/Huber/Stieber
Introduction
Ionizing radiation is established as an essential part of
the therapy of many malignant diseases. Similar to che-
motherapy, it affects mainly fast proliferating cells and
tissues with high turnover, such as tumor cells but also
stem cells, lymphocytes and epithelial cells [1]. Therefore
radiotherapy protocols aim both to reduce tumor size and
to limit potential side effects.
It is well known that radiation induces cell death al-
ready at low doses. Although still controversial, apoptosis
seems to play an important role in many cell types [2, 3].
However, oncosis and other forms of cell death may con-
tribute to cell loss particularly at high doses [4].
The effects of radiotherapy – single- and double-strand
DNA breaks – are mediated directly, by activation of the
CD95/Apo1/Fas receptor system and a proteolytic cas-
cade of caspases, or by stimulation of the mitochondria,
or by direct damage of the DNA. Often, p53 is upregu-
lated leading to an arrest of the cell cycle and activation of
repair systems [5–8]. In case of extended DNA damage or
insufficient repair mechanisms, the cells will die by apop-
tosis or other forms according to the cell type, their energy
level and the severity of the lesion [4]. These factors may
also influence the delay from the lethal hit to the cell de-
mise.
For the monitoring of the therapeutic efficacy, the
quantification of cell death can be applied directly by
microscopy or by measurement of cell death products
both in tumor tissue and in the circulating blood. The
most convenient und less invasive method is the detec-
tion of the final products in serum or plasma. If per-
formed during the therapy, it may provide an actual
image of the cell death kinetics.
Typical products of cell death are nucleosomes – com-
plexes which are formed from a core particle of several
histone components and DNA on the outside [9, 10]. Dur-
ing cell death, endonucleases preferentially bind to the
easy accessible linking sites between the nucleosomes and
cut the chromatin into multiple mono- and oligonucleo-
somes [11, 12]. In cases of enhanced cell death, e.g. during
radiotherapy, they are also released into the circulation
and can be detected in elevated amounts in serum or
plasma.
Former studies on serial measurements of nucleo-
somes in the serum of cancer patients during radiotherapy
revealed a steep increase in the nucleosomal number 1–3
days after the start of treatment followed by a decline that
showed interindividual differences in the time delay and
the rate of decrease. Patients with a rapid and complete
decline in the nucleosome number were found to have an
efficient reduction in the tumor volume; those with con-
stantly high values or a delayed and incomplete decrease
were correlated with a poor response to therapy and pro-
gressive disease [13].
As cells of various origin are degraded in (or also out-
side) the radiation field, it was highly interesting to
explore to which extent dying normal and tumor cells con-
tribute to the quantity of circulating nucleosomes and
whether the increase in nucleosomes during radiotherapy
reflects the extent of tumor cell apoptosis.
Addressing these questions, we investigated in vitro
the sensitivity of both cell types to radiation by exposing
normal epithelial cells and squamous lung cancer cells to
different doses of ionizing radiation. After this single hit,
the number of nucleosomes in the supernatant of the cell
cultures was quantified daily for 5 days in order to gain
insight in the dose- and time-dependent cell death pro-
cesses after irradiation.
Materials and Methods
Culture Techniques
BEAS-2B is an immortalised human bronchial epithelium cell
line and was kindly provided by Prof. D.A. Gillissen, Department of
Pneumology, University of Bonn, Germany. The EPLC 32M1 is an
adherent-growing non-small cell lung cancer line that was derived
from a human squamous-cell carcinoma [14] and was kindly pro-
vided by Dr. G. Jaques, University of Marburg, Germany.
Both cell lines were grown until they were confluent in multi-well
dishes (Falcon, Lincoln Park, N.J., USA) using RPMI 1640 culture
medium (Seromed, Heidelberg, Germany), supplemented with 10%
new born calf serum, 2 mM L-glutamine and antibiotics (all Lifetech-
nologies, Eggenstein, Germany) in a humidified 5% CO2 atmo-
sphere.
Irradiation of BEAS-2B and EPLC
Confluent BEAS-2B and EPLC were irradiated on a single occa-
sion with 0, 10 or 30 Gy in the Department of Radiotherapy, Ludwig-
Maximilians-University Munich, using the linear accelerator Sli 15
(Elekta, Hamburg, Germany) at a high dose of 4 Gy/min. The sham-
irradiated group (0 Gy) was subjected to the same procedure without
irradiation. A total of 18 BEAS-2B cultures and 18 EPLC were used
in the experiments.
Measurement of Nucleosomes
Immediately before and at 24-hour intervals (up to 96 h after irra-
diation), the supernatants of the BEAS-2B and EPLC cultures were
changed, aliquoted, frozen at –20 °C and transferred to the Institute
of Clinical Chemistry of the Ludwig-Maximilians-University. The
concentration of the nucleosomes was measured using a modified
version of the Cell Death Detectionplus-ELISA (Roche Diagnostics,
Germany) [15].
The Cell Death Detectionplus-ELISA is based on a quantitative
sandwich enzyme immunoassay principle: monoclonal mouse anti-
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bodies directed against DNA (ss- and ds-DNA) and histones (H1,
H2A, H2B, H3 and H4) detect specifically mono- and oligonucleo-
somes.
The supernatant was placed in a streptavidin-coated microtiter
plate and incubated with a mixture of anti-histone-biotin, anti-DNA-
peroxidase and incubation buffer (1% BSA, 0.5% Tween, 1 mM
EDTA in PBS) for 2 h. The antibodies bound to the histone and
DNA component of the nucleosomes, respectively, and fixed the
immunocomplexes to the microtiter plate by streptavidin-biotin
interaction. After the incubation period, unbound antibodies were
removed by a washing step. The retained peroxidase-linked com-
plexes were incubated with 2,2)-azino-di(3-ethylbenzthiazolin-sul-
fonate). The substrate reacted with the peroxidase resulting in color
development proportional to the amount of nucleosomes captured in
the antibody-sandwich. Quantification of the nucleosomes was per-
formed by photometrical determination of the absorbance at 405 nm
against substrate solution as blank (reference wavelength 492 nm).
Measurement of Cell Number
BEAS-2B cells were grown in a second culture, and cells were har-
vested daily at the time the supernatant was changed in the first cul-
ture. Viable cells were identified using a trypan blue staining and
counted in a Neubauer counting chamber.
Statistics
The values in the text are expressed as medians and ranges. The
increases and decreases in the time-dependent kinetic investigations
are calculated between the several medians in percent changes. The
Wilcoxon test was used (1) to compare the experimental groups (con-
trol, and 10 and 30 Gy), (2) to compare the values during irradiation
with the pre-irradiation value and (3) to compare the values of two
specific groups (BEAS-2B and EPLC) which were treated with the
same doses (10 and 30 Gy). A p value !0.05 was considered statisti-
cally significant.
The values in the figures are presented as medians, and addition-
ally as 25th and 75th percentiles (bars).
Results
During the observation period, the cell number of non-
irradiated BEAS-2B increased slightly (median initially:
1.44 ! 106 cells/culture, range 1.07–1.85 ! 106 cells/cul-
ture; after 120 h: 4.81 B 3.18 ! 106 cells/culture, range
1.50–9.54 ! 106 cells/culture; increase of 235%). In
BEAS-2B irradiated with 10 Gy, the cell number de-
creased rapidly, reaching very low levels already after 72 h
(0.27 ! 106 cells/culture, range 0.05–0.39 ! 106 cells/cul-
ture) corresponding with a decrease of 81% (p = 0.031). In
BEAS-2B irradiated with 30 Gy, the reduction in the cell
number started already after 24 h, and after 72 h it
reached 0.19 ! 106 cells/culture (range 0.09–0.31 ! 106
cells/culture) corresponding to a decrease of 87% (p =
0.031). The decline in the values continued during the fol-
lowing days. The lowest numbers were obtained after
120 h (10 Gy: 0.03 ! 106 cells/culture, range 0.02–0.08 !
Fig. 1. Kinetics of the cell number of normal BEAS-2B (medians)
without irradiation ($ ) (control group) and after irradiation with
10 Gy (d) and 30 Gy (P). Cells were harvested before irradiation
(0 h), and 24, 48, 72, 96 and 120 h after single-dose irradiation.
106 cells/culture, decrease of 98%; 30 Gy: 0.08 ! 106
cells/culture, range 0.02–0.14 ! 106 cells/culture, de-
crease of 95%), being highly significant (10 Gy: p = 0.005,
30 Gy: p = 0.005) compared with the non-irradiated con-
trol group (4.81 ! 106 cells/culture, range 1.50–9.54 !
106 cells/culture) (fig. 1).
Also, nucleosomes increased constantly and slightly in
the supernatant of non-irradiated BEAS-2B (initially:
0.18 ! 103 arbitrary units (AU), range 0.07–0.47 ! 103
AU; after 120 h: 0.63 ! 103 AU, range 0.44–2.17 ! 103
AU; increase of 246%). However, after irradiation with
10 Gy, BEAS-2B increased rapidly reaching a maximum
at 72 h (before irradiation: 0.24 ! 103 AU, range 0.13–
4.09 ! 103 AU; after 72 h: 1.94 ! 103 AU, range 0.11–
5.70 ! 103 AU; increase of 693%; p = 0.219) and after
120 h almost dropped to values before treatment (0.30 !
103 AU, range 0.07–0.55 ! 103 AU; decrease of 537%).
At 30 Gy, the release was even stronger, with an earlier
peak already after 48 h (before irradiation: 0.29 ! 103
AU, range 0.14–2.68 ! 103 AU; after 48 h: 11.09 ! 103
AU, range 6.89–18.28 ! 103 AU; increase of 3,763%; p =
0.031) followed by a decline to low levels after 120 h
(0.82 ! 103 AU, range 0.24–1.36 ! 103 AU; decrease of
1,245%). For all time points investigated immediately
after irradiation (24–96 h), the differences between the
sham group and the group irradiated with 30 Gy were
highly significant (p ! 0.05) (fig. 2).
In non-irradiated EPLC, the levels of nucleosomes
increased constantly (initially: 2.48 ! 103 AU, range
1.58–4.83 ! 103 AU; after 96 h: 5.14 ! 103 AU, range
2.80–11.82 ! 103 AU; increase of 107%). In EPLC irra-
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Fig. 2. Release of nucleosomes after irradiation of normal BEAS-2B
(medians) without irradiation ($ ) (control group) and after irradia-
tion with 10 Gy (d) and 30 Gy (P). Nucleosomes were measured in
the culture supernatant before irradiation (0 h), and 24, 48, 72, 96
and 120 h after single-dose irradiation.
Fig. 3. Release of nucleosomes after irradiation of EPLC (medians)
without irradiation ($ ) (control group) and after irradiation with
10 Gy (d) and 30 Gy (P). Nucleosomes were measured in the cul-
ture supernatant before irradiation (0 h), and 24, 48, 72 and 96 h
after single-dose irradiation.
Fig. 4. Release of nucleosomes after irradiation of BEAS-2B (k) and
EPLC (Z) with 10 Gy. Nucleosomes were measured in the culture
supernatant before irradiation (0 h), and 24, 48, 72 and 96 h after
single-dose irradiation. Medians, and 25th and 75th percentiles are
shown. p values indicating differences between the groups were cal-
culated by Wilcoxon test.
Fig. 5. Release of nucleosomes after irradiation of BEAS-2B (k) and
EPLC (Z) with 30 Gy. Nucleosomes were measured in the culture
supernatant before irradiation (0 h), and 24, 48, 72 and 96 h after
single-dose irradiation. Medians, and 25th and 75th percentiles are
shown. p values indicating differences between the groups were cal-
culated by Wilcoxon test.
diated with 10 Gy, we observed a considerably higher
release of nucleosomes with the maximum again at 72 h
(before irradiation: 2.79 ! 103 AU, range 2.42–3.80 !
103 AU; after 72 h: 7.16 ! 103 AU, range 4.30–16.20 !
103 AU; increase of 157%; p = 0.031). After 96 h, the val-
ues were comparable with the non-irradiated group (5.31
! 103 AU, range 4.71–13.76 ! 103 AU). In EPLC treated
with 30 Gy, the maximum (6.22 ! 103 AU, range 5.13–
9.71 ! 103 AU; increase of 180%; p = 0.031) was
observed already after 24 h followed by a slow decline (af-
ter 96 h: 4.19 ! 103 AU, range 3.29–9.27 ! 103 AU)
(fig. 3).
Comparing BEAS-2B and EPLC which were irradiated
with 10 Gy, EPLC started before therapy from a higher
level (EPLC: 2.79 ! 103 AU, range 2.42–3.80 ! 103 AU;
BEAS-2B: 0.24 ! 103 AU, range 0.13–4.09 ! 103 AU;
p = 0.054) and exhibited a stronger increase. After 72 h,
EPLC levels (7.16 ! 103 AU, range 4.30–16.20 ! 103
AU) were more than 3.5 times higher than BEAS-2B lev-
els (1.94 ! 103 AU, range 0.11–5.70 ! 103 AU; p =
0.016). The subsequent decline after 96 h was less pro-
nounced in EPLC than in BEAS-2B (EPLC: 5.31 ! 103
AU, range 4.71–13.76 ! 103 AU; BEAS-2B: 0.37 ! 103
AU, range 0.22–1.04 ! 103 AU; p = 0.004) (fig. 4).
2
3
4
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After irradiation with 30 Gy, both cell lines showed a
rapid and strong increase. The release of nucleosomes of
BEAS-2B (with its maximum after 48 h) was significantly
higher than that of EPLC (BEAS-2B: 11.09 ! 103 AU,
range 6.89–18.28 ! 103 AU; EPLC: 5.95 ! 103 AU,
range 4.31–8.35 ! 103 AU; p = 0.010). However, nucleo-
some values from EPLC reached their peak already after
24 h. Once again, the following decrease in the values was
more pronounced for BEAS-2B than for EPLC after 96 h
(BEA-2B: 1.99 ! 103 AU, range 0.72–3.93 ! 103 AU;
EPLC: 4.19 ! 103 AU, range 3.29–9.27 ! 103 AU; p =
0.016) (fig. 5).
Discussion
The induction of cell death in malignant cells is the
basis of the antitumor effect of ionizing radiation. Besides
cancer cells, normal epithelial cells, lymphocytes and
stem cells are also damaged and killed leading potentially
to complications during therapy [1]. In order to reduce
tumor size and to limit side effects, several protocols have
been developed optimizing dosage and frequency of ra-
diotherapy. The monitoring of the response to radiothera-
py is mainly performed by imaging techniques. However,
for early information and for serial measurements, serum
biomarkers indicating the extent of cell death would be
valuable for predicting response to therapy and treatment
monitoring. In a recent study in 16 patients with various
cancers, we described that the kinetics of nucleosomes,
during the initial phase of radiotherapy, correlated with
the clinical outcome that was estimated by imaging tech-
niques later on [13]. As these nucleosomes could derive
from various origins, we investigated here in vitro the
dose- and time-dependent release of nucleosomes in nor-
mal and malignant bronchoepithelial cells of the lung in
order to estimate the contribution of both cell types to the
nucleosome values obtained.
The effective damage of the cells by irradiation was
shown by the rapid and complete reduction in the cell
number in BEAS-2B irradiated with 10 and 30 Gy. In
contrast, non-irradiated BEAS-2B exhibited a constantly
increasing cell number. In EPLC the cell number was
quantified only 96 h after irradiation, which was compa-
rable to the results of BEAS-2B (data not shown).
It is likely that the increasing amount of untreated cells
is not only due to proliferation but also to cell death pro-
cesses. Strong evidence for this hypothesis is given by the
values of nucleosomes which reflect the extent of cell
death. They increased in parallel and in a comparable
magnitude with the cell number in BEAS-2B. A similar
phenomenon was observed in EPLC, but nucleosome val-
ues started initially from a higher level. This indicates a
higher spontaneous turnover in malignant cells and corre-
lates with in vivo findings of elevated spontaneous nu-
cleosome values in the serum of patients with malignant
diseases [13, 16]. Even if the cell number is decreasing
rapidly in irradiated cell lines, a mixture of degradation
and proliferation might still occur only with a stronger
prevalence of cell death.
Nucleosomes increased in both BEAS-2B and EPLC
during irradiation in a dose- and time-dependent manner.
As nucleosomes are intracellular components released
during cell death, their quantity reflects the number of
cells dying spontaneously or after lethal damage by irra-
diation. Generally, the cell killing effect of radiation was
observed in both BEAS-2B and EPLC as a considerable
increase in nucleosomes after treatment with 10 and with
30 Gy.
A dosage of 30 Gy resulted in an early (after 24 to 48 h)
and high maximum of nucleosomes. Because of the strong
damage, many cells are probably killed immediately after
exposure to irradiation and are not able to activate any
cellular rescuing mechanisms. At 10 Gy, the maximum
was observed later and less pronounced compared with
the higher dosage in BEAS-2B. In this case, cells might
still have the possibility to arrest their cell cycle and
enable the repair of DNA damages. Only if they cannot be
compensated appropriately, these cells will be determined
to undergo cell death later on [17]. This hypothesis is sup-
ported by the well-known upregulation of p53 after radia-
tion-induced DNA damages. p53 is involved in cell cycle
arrest as well as in the regulation of apoptosis. In case of
extended damage, or dysfunctional or insufficient repair
systems, p53 induces apoptotic cell death by activation of
BAX, BAD, and the mitochondrial release of cytochrome
C [5–8]. Since tumor cells frequently exhibit a high spon-
taneous instability of DNA and their repair mechanisms
are often dysfunctional due to specific mutations, they are
likely to present a damaged DNA which cannot be elimi-
nated adequately [17, 18]. This explains the high sponta-
neous rate of cell death in malignant cells as well as their
high sensitivity to radio- and chemotherapy. Consistently,
in EPLC we found a strong effect of irradiation already at
10 Gy, which could not be enhanced by 30 Gy.
Comparing BEAS-2B and EPLC, the maximum ob-
tained after irradiation with 10 Gy was significantly high-
er in EPLC, underlining the high sensitivity of tumor cells
to irradiation. After irradiation with 30 Gy, both cell lines
demonstrated a rapid and strong increase, with BEAS-2B
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reaching higher maximum levels. Subsequently, the val-
ues dropped more significantly in BEAS-2B than in EPLC
probably caused by the higher rate of spontaneous prolif-
eration and cell death in EPLC.
The massive induction of apoptosis in HeLa Hep2
cells has been described earlier in an immunohistochemi-
cal study by Mirzaie-Joniani et al. [3]. Up to 60% of the
cells irradiated with 5 and 15 Gy displayed apoptotic
characteristics detected by TUNEL and M30 Cyto-
DEATH technology. Doses below 2 Gy did not have any
effect. The highest induction rate was seen after treatment
with 5 Gy. Higher doses did not significantly raise apop-
totic rates. The values increased already after 24 h and
reached the peak after 168 h [3]. Unfortunately, the values
between 72 h and 168 h after irradiation were not investi-
gated.
In accordance with this study, we confirm that tech-
niques measuring cell death characteristics are useful
tools for the estimation of in vitro radiosensitivity in cell
lines. Further, we demonstrated that nucleosomes reflect
the extent of cell death induced by irradiation. Our results
indicate that normal bronchoepithelial and malignant
lung cancer cells contribute to the release of nucleosomes
during irradiation in a dose- and time-dependent manner.
At low doses, cancer cells had a clearly higher effect on the
release of nucleosomes.
In vivo, the situation during radiotherapy is more com-
plex: Normal and malignant cells integrated in tissue
might react differently to irradiation possibly in relation
to the linkage with adjacent cells. Therefore, further stud-
ies in whole organ cultures consisting of tumor cells, fibro-
blasts and normal bronchoepithelial cells might reveal
new insights in tissue radiosensitivity [19, 20].
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